Plasma treatment reduces death risk in coronavirus patients, new study says

$%name Plasma treatment reduces death risk in coronavirus patients, new study says by Authcom, Nova Scotia\s Internet and Computing Solutions Provider in Kentville, Annapolis Valley$

A new coronavirus study from Italy shows that plasma therapy can significantly reduce COVID-19 mortality in moderate to severe cases.
The research shows plasma transfusion from COVID-19 survivors can improve the overall condition of patients and reduce the risk of complications and death.
The study also indicates that antibody-based coronavirus treatment can yield results, and synthetic antibody drugs could be equally effective.
Visit BGR’s homepage for more stories.

The novel coronavirus is here to stay, experts warned this week. But that’s not as bad as it may sound. We’ve learned how to live with all sorts of pathogens over the years. Medical breakthroughs eradicated some of them, but others are harder to kill. Take the flu and AIDS, which keep spreading despite our best efforts. Yet both diseases can be managed successfully, as we have plenty of therapies that are safe and effective.

The same will be true of COVID-19 in the not-so-distant future. We might have a reliable cure even before vaccines are widely deployed, and we’ve seen a mountain of evidence to support that idea. Doctors have repurposed several drugs for COVID-19 therapy and are in the midst of creating antibody-based medications that could speed up recovery. A new study suggests antibody therapy can be useful, as doctors from Italy proved that plasma transfusion from recovered COVID-19 patients can reduce mortality rates in severe cases.

Continue reading…

Today’s Top Deals

Trending Right Now:

Plasma treatment reduces death risk in coronavirus patients, new study says originally appeared on BGR.com on Thu, 14 May 2020 at 21:09:15 EDT. Please see our terms for use of feeds.